Press Releases - 2021-06-10

Date	Title	Company
10-Jun-2021	Global Atopic Dermatitis Pipeline Insight Research Report 2021 - ResearchAndMarkets.com	Businesswire
10-Jun-2021	Biomedical Materials Market Size 2021, Share, Global Trends, Comprehensive Research Study, Development Status\| Institut Straumann AG, Dentsply Sirona, Danaher, BIOLASE	The Wire Times
10-Jun-2021	AtbFinder Test System Shows Promise to Select Effective Antibiotic Regimens to Fight Deadly Lung Infections	Newswire
10-Jun-2021	Allergy Treatment Market Size 2021-Industry Share, Growth Factors, Top Leaders, Development Strategy, Future Trends\| Johnson & Johnson Services, Novartis AG, Cipla	The Wire Times
10-Jun-2021	Migraine Drugs Market Size, Share, Global Industry Recent Trends, Demand and Share Estimation by 2028 with Top Players-Abbott, Aegis Theraputics, LLC, Aerial BioPharma LLC	The Wire Times
10-Jun-2021	Enanta Pharmaceuticals to Participate in Two Investor Conferences in June	Businesswire
10-Jun-2021	Adaptive Phage Therapeutics Announces Collaboration with Oyster Point Pharma to Target Ophthalmic Diseases	Businesswire
10-Jun-2021	Onchilles Pharma Raises $7 Million Series A to Advance Drug Candidates to Activate Newly Discovered Broad-Acting Anticancer Pathway	Businesswire
10-Jun-2021	Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR	Businesswire
10-Jun-2021	Bristol Myers Squibb Announces Positive Topline Results from Phase 3 TRANSFORM Trial Evaluating Breyanzi (lisocabtagene maraleucel) Versus Chemotherapy Followed by Stem Cell Transplant in Second-line Relapsed or Refractory Large B-cell Lymphoma	Businesswire
10-Jun-2021	Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antiresorptive treatment for osteoporosis, a biosimilar of reference medicine Prolia®, in Europe, the UK, Switzerland, and Australia	Theramex
10-Jun-2021	BSI and Poseidon to collaborate on global, multi-modal Good Distribution Practice (GDP) compliance program for medicines and vaccines	BSI
10-Jun-2021	Polylactic Acid Markets, 2026 - Key Players are Corbion N.V., Toray, BASF SE, Mitsubishi Chemical, and DowDuPont - ResearchAndMarkets.com	Businesswire
10-Jun-2021	Global In-Mold Labels Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com	Businesswire
10-Jun-2021	New way to 3D-print custom medical devices to boost performance and bacterial resistance	University of Nottingham
10-Jun-2021	Positive clinical data on the novel non-opioid VR1 antagonist ACD440 presented at IASP pain conference	AlzeCure Pharma AB
10-Jun-2021	Quantum Computing: Boehringer Ingelheim is a Founding Member of QUTAC	Quantum Computing
10-Jun-2021	Immutep reveals a new anti-LAG-3 research program	Immutep Limited (
10-Jun-2021	Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round	Actimed Therapeutics
10-Jun-2021	Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China	Verona Pharma & Nuance Pharma